Table 2 Comparison of initial CT findings and scores between groups.
From: Quantitative inspiratory–expiratory chest CT findings in COVID-19 survivors at the 6-month follow-up
Characteristics | All patients (n = 205) | Group 1 (n = 88) | Group 2 (n = 117) | p value |
|---|---|---|---|---|
Time from symptoms onset to CT scan(days) | 24 ± 16 | 26 ± 17 | 22 ± 15 | 0.102 |
Lung involvement | ||||
Unilateral | 5/205 (2.4%) | 3/88 (3.4%) | 2/117 (1.7%) | 0.653 |
Bilateral | 200/205 (98%) | 85/88 (97%) | 115/117 (98%) | |
Predominant CT pattern | ||||
GGO | 179/205 (87%) | 80/88 (91%) | 99/117 (85%) | 0.388 |
Consolidation | 15/205 (7.3%) | 5/88 (5.7%) | 10/117 (8.5%) | |
Reticulation | 11/205 (5.4%) | 3/88 (3.4%) | 3/117 (3.4%) | |
Presence of nodule or mass | 2/205 (1%) | 1/88 (1.1%) | 1/117 (0.9%) | 0.833 |
Pleural effusion | 23/205 (11%) | 11/88 (13%) | 12/117 (10%) | 0.660 |
Thickening of the adjacent pleura | 62/205 (30%) | 31/88 (35%) | 31/117 (27%) | 0.178 |
Honeycombing | 1/205 (0.5%) | 1/88 (1.1%) | 0/117 (0%) | 0.248 |
Bronchiectasis | 11/205 (5.4%) | 7/88 (8%) | 4/117 (3.4%) | 0.212 |
CT score | ||||
Total lesions | 13 ± 8 | 15 ± 8 | 12 ± 7 | 0.004 |
GGO | 12 ± 8 | 14 ± 8 | 11 ± 7 | 0.001 |
Consolidation | 4 ± 5 | 4 ± 4 | 4 ± 5 | 0.833 |
Reticular | 4 ± 5 | 5 ± 5 | 4 ± 4 | 0.002 |
